AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ARROWHEAD PHARMACEUTICALS, INC. Director's Dealing 2020

Sep 9, 2020

31071_dirs_2020-09-08_b321f4cd-f0d2-4641-900f-35b0ba431db2.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2020-09-01

Reporting Person: OLUKOTUN ADEOYE Y (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Direct

Footnotes

F1: Includes a total of 5,000 shares underlying restricted stock units, which will vest in September 2021.